These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 21767697

  • 1. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C, Pérez-Álvarez R.
    Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
    [Abstract] [Full Text] [Related]

  • 2. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
    Mousa N, Besheer T, Gad Y, Elbendary A, Mokbel T, Abdel-Aziz A.
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
    [Abstract] [Full Text] [Related]

  • 3. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
    Ann Intern Med; 2013 Dec 03; 159(11):I-14. PubMed ID: 24297207
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
    Espinosa M, Hernàndez J, Arenas MD, Carnicer F, Caramelo C, Fabrizi F.
    Kidney Blood Press Res; 2015 Dec 03; 40(3):258-65. PubMed ID: 25997572
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM, Khalaf H, Ibraheem H, Rady H, Helmy AK.
    Int J Infect Dis; 2012 Jan 03; 16(1):e67-71. PubMed ID: 22115957
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
    Iferkhass S, Elasri F, Chatioui S, Khoyaali A, Bargach T, Reda K, Oubaaz A.
    J Fr Ophtalmol; 2015 Jan 03; 38(1):34-40. PubMed ID: 25533994
    [Abstract] [Full Text] [Related]

  • 10. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening.
    Vujosevic S, Tempesta D, Noventa F, Midena E, Sebastiani G.
    Hepatology; 2012 Aug 03; 56(2):455-63. PubMed ID: 22331668
    [Abstract] [Full Text] [Related]

  • 11. [Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C].
    Zhdanov KV, Gusev DA, Kozlov KV, Shishkin MK, Sukachev VS, Shakhmanov DM, Zhabrov SS.
    Voen Med Zh; 2015 Apr 03; 336(4):44-9. PubMed ID: 26454938
    [Abstract] [Full Text] [Related]

  • 12. [Pegylated intereferon hematological safety in comparison with standard].
    Fazylov VKh, Manapova ÉR, Tkacheva SV, Sozinova IuM.
    Eksp Klin Gastroenterol; 2012 Apr 03; (6):96-9. PubMed ID: 23402198
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
    Ogawa E, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Dohmen K, Shimoda S, Hayashi J, Kyushu University Liver Disease Study [KULDS] Group.
    J Gastroenterol Hepatol; 2012 Jul 03; 27(7):1233-40. PubMed ID: 22098185
    [Abstract] [Full Text] [Related]

  • 14. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
    Schulman JA, Liang C, Kooragayala LM, King J.
    Ophthalmology; 2003 Feb 03; 110(2):437-42. PubMed ID: 12578794
    [Abstract] [Full Text] [Related]

  • 15. Retinal nerve fibre layer defects associated with cotton-wool spots in patients with interferon retinopathy.
    Hara K, Tanito M, Ohira A.
    Acta Ophthalmol; 2012 Mar 03; 90(2):e158-60. PubMed ID: 21649866
    [No Abstract] [Full Text] [Related]

  • 16. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
    Hu CC, Chien RN.
    Aliment Pharmacol Ther; 2013 Feb 03; 37(4):492. PubMed ID: 23336679
    [No Abstract] [Full Text] [Related]

  • 17. [Side effects of interferon-based therapy for chronic hepatitis C virus infection and clinical management of them].
    Iwasaki Y, Ikeda F, Yamamoto K.
    Nihon Rinsho; 2011 May 03; 69 Suppl 4():215-20. PubMed ID: 22096922
    [No Abstract] [Full Text] [Related]

  • 18. Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.
    Slim J, Afridi MS.
    Infect Dis Clin North Am; 2012 Dec 03; 26(4):917-29. PubMed ID: 23083824
    [Abstract] [Full Text] [Related]

  • 19. Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin.
    Novelli FJ, Przysiezny A, Rosa EL, Garcia RF, Nóbrega MJ.
    Arq Bras Oftalmol; 2014 Dec 03; 77(3):178-81. PubMed ID: 25295906
    [Abstract] [Full Text] [Related]

  • 20. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Kang HM, Park MJ, Hwang JM, Kim JW, Jeong SH.
    Korean J Hepatol; 2009 Jun 03; 15(2):209-15. PubMed ID: 19581773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.